XML 29 R20.htm IDEA: XBRL DOCUMENT v3.25.3
Stockholders' Equity (Tables)
 9 Months Ended
Sep. 30, 2025
Stockholders' Equity Note [Abstract]  
Schedule of Dividends Paid Previously or Declared
The following table presents the cash dividends either paid previously or declared by our board of directors for future payment on a per share basis during 2025 and 2024:
20252024
First quarter$0.215 $0.195 
Second quarter0.220 0.195 
Third quarter0.220 0.195 
Fourth quarter0.220 0.195 
Total$0.875 $0.780 
Stock Options Granted
The following tables summarize the details of options granted under our stock option plans that were outstanding as of September 30, 2025, and the assumptions used to value those grants. All such grants were effective at the close of business on the grant date.
 Options
Granted		Option Exercise
Price		Closing Stock Price on Grant DateSeptember 30, 2025
Date of GrantOptions
Outstanding		Options
Exercisable
January 2, 20251,366,636 $36.00 $35.555 1,281,038 88,028 
January 2, 20241,629,824 $32.00 $31.775 1,392,342 300,986 
January 3, 20232,143,886 $24.00 $23.700 1,550,945 536,287 
January 3, 20221,426,876 $31.00 $30.990 941,828 495,346 
January 4, 20211,483,020 $24.00 $23.825 828,030 537,944 
January 2, 20201,804,526 $19.00 $18.615 808,286 646,308 
January 2, 20192,633,848 $13.00 $12.853 711,606 565,046 
January 2, 20182,175,872 $13.75 $13.635 350,098 284,918 
January 3, 20173,059,156 $11.75 $11.738 161,302 161,302 
Total17,723,644 8,025,475 3,616,165 
Fair Value Assumptions for Options Granted
Date of GrantRisk-free
Interest Rate		Expected Life
of Option in
Years		Expected
Dividend
Yield		Expected
Stock
Volatility		Estimated Fair
Value of Stock
Option
January 2, 20254.3%5.002.2%27.36%$8.86 
January 2, 20243.8%5.002.2%28.44%$7.94 
January 3, 20234.0%5.002.6%29.58%$5.81 
January 3, 20221.3%5.001.7%28.52%$6.84 
January 4, 20210.4%5.002.0%29.17%$4.79 
January 2, 20201.7%5.002.4%25.70%$3.41 
January 2, 20192.5%5.002.9%23.96%$2.20 
January 2, 20182.2%5.002.3%23.45%$2.51 
January 3, 20171.9%5.002.6%24.49%$2.10 
Reconciliation of Denominators Used in Computation of Basic and Diluted Net Income Per Share
The following tables present a reconciliation of the denominators used in the computation of basic and diluted net income per share and a summary of the options to purchase shares of common stock which were excluded from the diluted net income per share calculation because they were anti-dilutive:
 Nine-month PeriodThree-month Period
Reconciliation2025202420252024
Basic weighted average shares outstanding1,147,437,856 1,145,102,552 1,147,871,234 1,145,470,410 
Weighted shares assumed upon exercise of stock options2,814,160 3,169,300 3,165,397 2,896,912 
Diluted weighted average shares outstanding1,150,252,016 1,148,271,852 1,151,036,631 1,148,367,322 
Anti-Dilutive Options Excluded
 Nine-month PeriodThree-month Period
Summary of Anti-dilutive Options Excluded2025202420252024
Options to purchase shares of common stock1,188,640 2,461,662 — 2,455,992 
Weighted average exercise prices of options$36.00 31.59 $— 31.60